Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic amyloidosis: are we moving ahead?

G Merlini

    The Netherlands Journal of Medicine
    |July 17, 2004
    PubMed
    Summary

    Systemic amyloidoses require precise amyloid typing for accurate diagnosis and treatment. Understanding molecular mechanisms is key to developing new therapies that target precursor supply.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Factors influencing equine embryo outcomes in OPU‑ICSI systems: Insights from a large‑scale program in Brazil.

    Journal of equine veterinary science·2026
    Same author

    Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.

    European journal of neurology·2020
    Same author

    Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.

    Journal of hematology & oncology·2018
    Same author

    Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

    Leukemia·2016
    Same author

    Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.

    Leukemia·2016
    Same author

    Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients.

    Leukemia·2014

    Area of Science:

    • Hematology
    • Pathology
    • Molecular Biology

    Background:

    • Systemic amyloidoses encompass diverse diseases with variable clinical outcomes.
    • Accurate identification of amyloid deposit types is crucial for effective patient management.
    • Current treatments focus on reducing the production of amyloidogenic precursors.

    Discussion:

    • The heterogeneity of systemic amyloidoses necessitates precise diagnostic methods.
    • Therapeutic strategies are evolving towards precursor-directed interventions.
    • Molecular insights into amyloidogenesis are fundamental for advancing treatment paradigms.

    Key Insights:

    • Precise amyloid typing is essential for diagnosing and treating systemic amyloidoses.
    • Eliminating amyloidogenic precursor supply is the cornerstone of current effective therapies.
    • Advancements in understanding molecular mechanisms will drive novel therapeutic development.

    Outlook:

    • Future therapies for systemic amyloidoses will emerge from a deeper comprehension of molecular pathways.
    • Continued research into the pathogenesis of amyloidosis is vital for improving patient prognoses.
    • Personalized treatment approaches may arise from detailed amyloid typing and molecular profiling.

    Related Experiment Videos